Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

FDA Approves Two Additional Indications for Rivaroxaban in Children

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

December 21, 2021

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

News Daily News

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

November 25, 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

November 18, 2021

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

News Conference News

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

November 15, 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

News Conference News TCT 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

November 03, 2021

Long-term Anticoagulation After Unprovoked VTE: New Insights

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

September 13, 2021

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

News Daily News

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

June 23, 2021

FDA Approves Dabigatran for VTE in Children

News Daily News

FDA Approves Dabigatran for VTE in Children

June 22, 2021

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

News Daily News

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

April 09, 2021

VTE Related to SARS-CoV-2 Infection Less of a Problem in Outpatients

News Daily News

VTE Related to SARS-CoV-2 Infection Less of a Problem in Outpatients

April 06, 2021

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

February 08, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.